Published in Histochem Cell Biol on February 09, 2016
Inflammation and cancer. Nature (2002) 53.78
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
Oxidative stress in Parkinson's disease. Ann Neurol (2003) 5.93
A unifying genetic model for facioscapulohumeral muscular dystrophy. Science (2010) 4.87
Biomarkers of oxidative damage in human disease. Clin Chem (2006) 4.40
Oxidative stress and cancer: have we moved forward? Biochem J (2007) 4.20
Role of oxidative stress in cardiovascular diseases. J Hypertens (2000) 3.73
Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet (2003) 3.60
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene (1999) 3.00
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet (2010) 2.95
Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet (2009) 2.90
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord (2007) 2.85
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet (2012) 2.82
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J (2008) 2.74
Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet (2006) 2.51
Pathways for mitotic homologous recombination in mammalian cells. Mutat Res (2003) 2.43
Facioscapulohumeral muscular dystrophy. Muscle Nerve (2006) 2.40
Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J (2007) 2.22
DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell (2011) 2.17
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2007) 2.06
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol (2010) 1.89
Some current insights into oxidative stress. Physiol Res (2009) 1.85
DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene (2001) 1.81
Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol Med (2011) 1.80
The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics (1995) 1.77
Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.73
DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol (2013) 1.72
Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem (2001) 1.68
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies. PLoS Genet (2011) 1.65
Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord (2003) 1.56
Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet (1996) 1.52
The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One (2011) 1.45
On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve Suppl (1995) 1.42
Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med (2008) 1.42
Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med (Berl) (2004) 1.39
Cancer risk among patients with myotonic muscular dystrophy. JAMA (2011) 1.38
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer (2011) 1.35
Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol (2010) 1.34
Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl Acad Sci U S A (2006) 1.32
The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol (2011) 1.29
Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2004) 1.13
Gene expression during normal and FSHD myogenesis. BMC Med Genomics (2011) 1.12
Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet (2009) 1.12
Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy. Neuromuscul Disord (2008) 1.06
A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One (2008) 1.01
Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother (2005) 1.01
Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. Am J Pathol (2009) 1.00
Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet (2014) 1.00
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2012) 0.99
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One (2011) 0.99
Dynamics of double strand breaks and chromosomal translocations. Mol Cancer (2014) 0.97
Rare hereditary diseases with defects in DNA-repair. Eur J Dermatol (2012) 0.94
Hearing loss in facioscapulohumeral muscular dystrophy. Neurology (1991) 0.92
Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscul Disord (2013) 0.90
Oxidative stress and tumour cell proliferation. Free Radic Res Commun (1990) 0.90
Increased cancer risks in myotonic dystrophy. Mayo Clin Proc (2012) 0.88
DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One (2013) 0.88
Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem (2013) 0.85
Fusion of EWSR1 with the DUX4 facioscapulohumeral muscular dystrophy region resulting from t(4;22)(q35;q12) in a case of embryonal rhabdomyosarcoma. Cancer Genet Cytogenet (2009) 0.85
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas. Trends Mol Med (2013) 0.79
Unusual association of FSHD and extramedullary thoracic tumour in the same patient: a case report. Acta Myol (2009) 0.76
A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer. Exp Oncol (2013) 0.76
Cancer-related genes in the transcription signature of facioscapulohumeral dystrophy myoblasts and myotubes. J Cell Mol Med (2013) 0.75
RNA-dependent disassembly of nuclear bodies. J Cell Sci (2016) 0.76
Functional roles of HIV-1 Tat protein in the nucleus. Cell Mol Life Sci (2015) 0.75
Control of DNA integrity in skeletal muscle under physiological and pathological conditions. Cell Mol Life Sci (2017) 0.75
HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells. Leukemia (2017) 0.75